Related Experiment Video
Updated: Sep 14, 2025

Assessing the Accuracy of Fitness Smartwatch Data for Cardiovascular and Physical Activity Monitoring: A Validation Study in Digital Health
Published on: February 21, 2025
Sleep Duration Irregularity and Risk for Incident Cardiovascular Disease in the UK Biobank
Tianyi Huang1, Sina Kianersi2, Heming Wang2,3
1Laboratory of Epidemiology and Population Sciences, Intramural Research Program National Institute on Aging Baltimore MD USA.
Background:
Emerging evidence supports a link between circadian disruption as measured by higher night-to-night variation in sleep duration and increased risk of cardiovascular disease (CVD). It remains unclear whether this association varies by CVD types or may be modified by average sleep duration and genetic risk for CVD.
Methods:
Our prospective analysis included 86 219 UK Biobank participants who were free from CVD when completing 7 days of accelerometer measurement from 2013 to 2015. Sleep irregularity was evaluated by the SD of accelerometer-measured sleep duration over 7 days. Incident major CVD events, defined as fatal or nonfatal myocardial infarction and stroke, were identified through linkage to Hospital Episode Statistics data until May 31, 2022. Multivariable-adjusted Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% CIs for associations of sleep duration SD with risk for major CVD events overall and for myocardial infarction and stroke separately.
Results:
We documented 2310 incident cases of major CVD events (myocardial infarction: 1183, stroke: 1175) over 636 258 person-years of follow-up. After adjusting for sociodemographic factors and family history of CVD, the HR associated with a 1-hour increase in sleep duration SD was 1.19 (95% CI, 1.10-1.27) for CVD (P-trend<0.0001), 1.23 (95% CI, 1.11-1.35) for myocardial infarction (P-trend<0.0001), and 1.17 (95% CI, 1.05-1.29) for stroke (P-trend=0.003). Additional adjustment for lifestyle factors, comorbidities, and sleep-related factors modestly attenuated these associations. Higher sleep irregularity was associated with higher CVD risk irrespective of genetic risk (P-interaction=0.43), but this association was stronger among individuals with longer average sleep duration >8 hours (P-interaction=0.006).
Conclusions:
Higher night-to-night variation in accelerometer-measured sleep duration was associated with consistently higher risks for major CVD events. The association did not seem to be modified by genetic risk for CVD and was more pronounced in long sleepers.
Related Concept Videos
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
Longitudinal Studies
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

